Search clinical trials for: Trametinib Dimethyl Sulfoxide
Total 1197 results
-
National Human Genome Research Institute (NHGRI)CompletedBRAF V600E MutationUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); American Lebanese Syrian Associated Charities...RecruitingLow Grade Glioma (LGG) of Brain With BRAF Aberration | High Grade Glioma (HGG) of the Brain With BRAF Aberration | Low Grade Glioma of Brain With Neurofibromatosis Type 1United States
-
National Cancer Institute (NCI)WithdrawnDabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 MutationsErdheim-Chester DiseaseUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8United States
-
Assaf-Harofeh Medical CenterUnknown
-
Assaf-Harofeh Medical CenterUnknown
-
Tishreen UniversityCompletedMild to Moderate Anterior Mandibular Segment CrowdindSyrian Arab Republic
-
U.S. Army Medical Research and Development CommandCompleted
-
GlaxoSmithKlineCompleted
-
Nova Scotia Health AuthorityTerminatedInterstitial Cystitis | Bladder DiseasesCanada
-
National Cancer Institute (NCI)Active, not recruitingStage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Unresectable MelanomaUnited States
-
Mayo ClinicCompletedOveractive Bladder | Detrusor Instability | Detrusor HyperreflexiaUnited States
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Completed
-
Rabin Medical CenterUnknownBreast Capsular Contracture | Dimethyl SulfoxideIsrael
-
National Cancer Institute (NCI)RecruitingGlioblastoma | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Astrocytoma, Not Otherwise Specified | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | WHO Grade 3 GliomaUnited States, Puerto Rico
-
NorthShore University HealthSystemCompletedInterstitial Cystitis | Painful Bladder Syndrome
-
National Cancer Institute (NCI)RecruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
National Cancer Institute (NCI)GlaxoSmithKline; Novartis PharmaceuticalsActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Metastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Locally Advanced Melanoma | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable...United States
-
Melanoma Institute AustraliaNovartisRecruiting
-
Dennis Bregner ZetnerCompletedBreast Cancer | Radiation Dermatitis | Radiation Dermatitis AcuteDenmark
-
Memorial Sloan Kettering Cancer CenterCompletedNon Small Cell Lung Cancer | KRAS Gene MutationUnited States
-
Medicines Development for Global HealthImperial College London; Phillip T. and Susan M. Ragon FoundationTerminatedHIV InfectionsUnited Kingdom
-
GlaxoSmithKlineCompleted
-
Napolitano MariasantaRegione SiciliaTerminatedThrombocytopenia | Primary Thrombocytopenia,Unspecified | Thrombocytopenia Chemotherapy InducedItaly
-
GlaxoSmithKlineCompleted
-
Maria Sklodowska-Curie National Research Institute...CompletedMultiple Myeloma | Lymphomas | LeukemiasPoland
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Recurrent Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Stanford UniversityBoston Children's HospitalRecruitingArterial Disease | Venous MalformationUnited States
-
Cairo UniversityUniversity of TurkuCompleted
-
The Netherlands Cancer InstituteGlaxoSmithKlineUnknown
-
Shanghai Henlius BiotechRecruiting
-
Dana-Farber Cancer InstituteNovartis; National Comprehensive Cancer NetworkTerminated
-
Universitair Ziekenhuis BrusselCompleted
-
University Health Network, TorontoNot yet recruitingArteriovenous Malformations
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant MelanomaUnited States
-
Adil DaudNational Comprehensive Cancer NetworkCompleted
-
GlaxoSmithKlineCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGastric Cancer | Metaplasia | Stage I Gastric Cancer | Initial-onset Gastric CancerJapan
-
Jonsson Comprehensive Cancer CenterNovartisNo longer availableProgressive Metastatic Castrate Resistant Prostate Cancer
-
Asan Medical CenterUnknownCancer | Lung Cancer Metastatic | BRAF V600EKorea, Republic of
-
Leiden University Medical CenterNovartisRecruitingAnaplastic Thyroid CancerNetherlands
-
Novartis PharmaceuticalsRecruitingBRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid TumorJapan
-
Novartis PharmaceuticalsCompletedMalignant MelanomaPortugal
-
University Hospital, EssenRecruitingMetastatic Thyroid CancerGermany
-
BiogenCompleted